Ching-Mei Chen
Overview
Explore the profile of Ching-Mei Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao M, Hao Y, Luo C, Chen C, Feng P, Yang H, et al.
J Liq Biopsy
. 2025 Mar;
6:100167.
PMID: 40027304
Objectives: Many cancer biomarkers such as the circulating tumor cells/microemboli (CTCs/CTM) have been reported significant associations with clinical outcomes. However, different biomarkers have different sensitivities and specificities for cancer types...
2.
Chen Y, Huang W, Lee W, Chen C, Cheng F, Kung C, et al.
Cancer Manag Res
. 2024 Aug;
16:989-1001.
PMID: 39108298
Background: The aim of this study was to investigate the role of phthalate in patients with esophageal squamous cell carcinoma (ESCC). Methods: A total of 116 ESCC patients and 58...
3.
Chen F, Chen C, Tsai C, Lu J, You H, Chen C, et al.
Front Endocrinol (Lausanne)
. 2023 Jun;
14:1173449.
PMID: 37334296
Background: Organophosphate flame retardants (OPFRs) are widely distributed in the environment and their metabolites are observed in urine, but little is known regarding OPFRs in a broad-spectrum young population from...
4.
Huang W, Yun T, Chew C, Chen A, Wei P, Lee K, et al.
Biomolecules
. 2022 Apr;
12(4).
PMID: 35454072
Immunotherapy is one of the most promising forms of cancer treatment. In particular, immune checkpoint blockers (ICBs) represent some of the leading candidates which many drug developers have heavily invested...
5.
Chen K, Lee K, Qin A, Luo C, Yeh Y, Zheng J, et al.
Adv Ther
. 2021 Dec;
39(2):910-922.
PMID: 34910280
Introduction: This study, for the first time to our knowledge, evaluated the efficacy of ropeginterferon alfa-2b, a long-acting pegylated interferon (IFN)-alfa, in the treatment of COVID-19. Methods: We retrospectively evaluated...
6.
Chen C, Chu T, Chou C, Chien C, Wang J, Huang C
Oral Oncol
. 2021 Jun;
120:105402.
PMID: 34174519
Objectives: microRNA (miRNA) expression patterns have provided new insight as biomarkers of prognosis as well as novel therapeutic targets for several neoplasms. However, the role of exosomal miRNA in the...
7.
Chen C, Anastasova S, Zhang K, Rosa B, Lo B, Assender H, et al.
IEEE J Biomed Health Inform
. 2019 Dec;
24(8):2208-2215.
PMID: 31804946
Excessive stress is one of the main causes of mental illness. Long-term exposure of stress could affect one's physiological wellbeing (such as hypertension) and psychological condition (such as depression). Multisensory...
8.
Tsay S, Tsay S, Ke C, Chen C, Tung H
J Am Assoc Nurse Pract
. 2018 Dec;
31(3):198-205.
PMID: 30550389
Background And Purpose: To date, there has been no policy analysis or review of the effectiveness of the current nurse practitioner (NP) scope of practice regulations in Taiwan. The purpose...
9.
Chen C, Chuang H, Lin Y, Fang F, Huang C, Chen C, et al.
Tumour Biol
. 2015 Sep;
37(2):1995-2005.
PMID: 26334621
CD105 is rich in endothelium cells and is involved in angiogenesis. Higher microvascular density of tumor is also related to the prognosis in a variety of cancers. In this present...
10.
Pan L, Chen C, Huang W, Sun C
Lab Med
. 2014 Apr;
45(1):32-6.
PMID: 24719982
Objective: To determine whether microcytic erythrocytes influence the accuracy of automated platelet (PLT) counting. Methods: We divided a total of 206 K2 ethylenediaminetetraacetic acid (EDTA)-anticoagulated blood samples into 4 groups,...